ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The treatment landscape in CDG"
Episode Synopsis
In this episode, we speak with Irena Muffels and Eva Morava about their recent review, The Therapeutic Future for Congenital Disorders of Glycosylation. We explore the three pillars they propose for advancing CDG treatment: improving disease models, enhancing clinical trial readiness, and finding scalable strategies that move us beyond one-gene-at-a-time approaches. From patient-derived brain organoids to AI-powered outcome assessments and the promise of basket trials, this conversation is a sweeping tour through the innovations shaping the future of CDG care.
The Therapeutic Future for Congenital Disorders of Glycosylation
I. J. J. Muffels, T. Kozicz, E. O. Perlstein, E. Morava
https://doi.org/10.1002/jimd.70011
The Therapeutic Future for Congenital Disorders of Glycosylation
I. J. J. Muffels, T. Kozicz, E. O. Perlstein, E. Morava
https://doi.org/10.1002/jimd.70011
More episodes of the podcast JIMD Podcasts
Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants
30/12/2025
Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff
23/12/2025
Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders
25/11/2025
IMD Research Round-Up: Mitochondrial disease
11/11/2025
In God we trust